Science and R&D
Navigate forward to interact with the calendar and select a date. Press the question mark key to get the keyboard shortcuts for changing dates.
Navigate backward to interact with the calendar and select a date. Press the question mark key to get the keyboard shortcuts for changing dates.
As nations engage in a race for global advantage in innovation, ITIF champions a new policy paradigm that ensures businesses and national economies can compete successfully by spurring public and private investment in foundational areas such as research, skills, and 21st century infrastructure. In the area of science and R&D policy, ITIF promotes public and private investment in research and development through public funding for research at national laboratories and universities, tax incentives to encourage business R&D, and policies to spur technology transfer from lab to market.
Featured
Why Congress Should Restore Full Expensing for Investments in Equipment and Research and Development
The tax law allowing firms to fully expense their research and development (R&D) costs expired at the end of 2021, and full expensing of equipment costs will begin phasing out in 2023. This decreases firms’ incentive to invest in these key drivers of economic growth and competitiveness. Congress should restore and make permanent full expensing for these investments.
More Publications and Events
October 8, 2024|Op-Eds & Contributed Articles
How to Win Techno-Economic Competition with China
It is often said that the Chinese economy cannot innovate. This is a dangerous assumption.
September 25, 2024|Blogs
Twelve Tax Reforms to Spur Innovation and Competitiveness
U.S. tax policy needs to prioritize innovation and competitiveness—especially as China rapidly gains ground as a leading innovator in advanced industries.
September 18, 2024|Events
Can China Innovate in Advanced Industries?
Please join the Information Technology and Innovation Foundation for an expert briefing event to discuss the findings of a 20-month ITIF investigation into Chinese firms’ innovative capabilities in key advanced industries, including robotics, chemicals, nuclear power, electric vehicles, semiconductors, AI, quantum computing, and biotechnology.
September 16, 2024|Reports & Briefings
China Is Rapidly Becoming a Leading Innovator in Advanced Industries
There may be no more important question for the West’s competitive position in advanced industries than whether China is becoming a rival innovator. While the evidence suggests it hasn’t yet taken the overall lead, it has pulled ahead in certain areas, and in many others Chinese firms will likely equal or surpass Western firms within a decade or so.
September 16, 2024|Reports & Briefings
How Innovative Is China in the Display Industry?
Chinese companies have become leading innovators in display technologies, in addition to becoming the largest global producers. China’s display industry has grown as a result of extensive subsidies, rampant intellectual property theft, and economies of scale.
September 9, 2024|Reports & Briefings
How Innovative Is China in Quantum?
China’s lead in quantum communications is undeniable, but its overall quantum prowess is limited; without computing breakthroughs, the United States still holds the upper hand.
September 3, 2024|Reports & Briefings
A Techno-Economic Agenda for Canada’s Next Federal Government
Innovation, productivity, and competitiveness must be top priorities for Canada’s next federal government, not sidenotes or vague aspirations to be addressed with little more than lip service.
August 19, 2024|Reports & Briefings
How Innovative Is China in Semiconductors?
China stands about five years behind global leaders in high-volume manufacturing of leading-edge logic semiconductor chips, and continues to trail in memory chips and semiconductor manufacturing equipment, although Chinese firms have made inroads in semiconductor design and production of legacy semiconductor chips.
August 12, 2024|Blogs
Fact of the Week: Global R&D Investment by Biopharmaceutical Companies Was $276 Billion in 2021
A recent article found that all previous reports of the biopharmaceutical industry have grossly underestimated total research and development expenditures.
August 6, 2024|Blogs
ITIF’s Innovation Policy Reading List for Summer 2024
To save you a trip to the library or bookstore, this list includes not just books we recommend for policy wonks and the general public alike, but also books we do not recommend.